In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia

BACKGROUND: Cell therapy has been proposed for patients with critical limb ischemia (CLI). Autologous bone marrow derived cells (BMCs) have been mostly used, mesenchymal stem cells (MSCs) being an alternative. The aim of this study was to characterize two types of MSCs and evaluate their efficacy. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Rifai, Rida, Nguyen, Philippe, Bouland, Nicole, Terryn, Christine, Kanagaratnam, Lukshe, Poitevin, Gaël, François, Caroline, Boisson-Vidal, Catherine, Sevestre, Marie-Antoinette, Tournois, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688282/
https://www.ncbi.nlm.nih.gov/pubmed/31399109
http://dx.doi.org/10.1186/s12967-019-2003-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688282/
https://www.ncbi.nlm.nih.gov/pubmed/31399109
http://dx.doi.org/10.1186/s12967-019-2003-3

Ejemplares similares